Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature

被引:11
|
作者
Veccia, Antonello [1 ]
Kinspergher, Stefania [1 ]
Grego, Elisabetta [1 ]
Peterlana, Dimitri [2 ]
Berti, Alvise [3 ]
Tranquillini, Enzo
Caffo, Orazio [1 ]
机构
[1] Santa Chiara Hosp, Med Oncol, Largo Medaglie Oro 1, I-38122 Trento, Italy
[2] Santa Chiara Hosp, Internal Med, Trento, Italy
[3] Santa Chiara Hosp, Neurol, Trento, Italy
关键词
lung cancer; myasthenia; myositis; nivolumab; CELL; DOCETAXEL; COMPLICATIONS; GRAVIS;
D O I
10.1097/CAD.0000000000000903
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The immunotherapy significantly improved survival of non-small cell lung cancer patients, but it may cause immune-related adverse events, which are severe in less than 10% of cases. We report the case of one patient who developed myositis and myasthenia during nivolumab treatment for metastatic lung squamous carcinoma. Moreover, we reviewed literature data in order to identify similar cases in cancer patients treated with immune-checkpoints inhibitors. A 65-year-old patient, who had previously received a first-line platinum-based therapy, developed diplopia and ptosis 4 weeks after the start of nivolumab. Although antibodies associated with myositis, myasthenia gravis and paraneoplastic syndromes were absent, immune-related myositis and myasthenia were diagnosed. Corticosteroids, immunoglobulin and pyridostigmine showed poor efficacy and the patient died 7 weeks after the appearance of the first symptoms. Fifteen similar cases were found in the literature. A close collaboration between different specialists is essential to rapidly identify and treat severe immune-related adverse events.
引用
收藏
页码:540 / 544
页数:5
相关论文
共 50 条
  • [41] Lung cancer with breast metastasis: a case report and review of the literature
    Cao, Xuan
    Chen, Peiqing
    Agyekum, Enock Adjei
    Zhang, Qing
    Qian, Xiaoqin
    Wu, Ting
    Chambers, Kevoyne Hakeem
    Yin, Liang
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (07)
  • [42] Nivolumab-induced synchronous occurrence of myositis and hypothyroidism in a patient with squamous cell lung cancer
    Badovinac, Sonja
    Korsic, Marta
    Zarkovic, Kamelija
    Mursic, Davorka
    Roglic, Mihovil
    Jakopovic, Marko
    Samarzija, Miroslav
    IMMUNOTHERAPY, 2018, 10 (06) : 427 - 431
  • [43] Granulomatous myositis associated with brucellosis: A case report and literature review
    Kojan, Suleiman
    Alothman, Adel
    Althani, Ziad
    Alshehri, Ali
    Mansour, Nouf
    Khathaami, Ali
    Haider, Abdulrazzaq
    Al-Jumah, Mohammed
    MUSCLE & NERVE, 2012, 45 (02) : 290 - 293
  • [44] Aspergillus-Related Myositis: A Case Report and Review of the Literature
    Zaidan, Mohamad
    Ottaviani, Sebastien
    Polivka, Marc
    Bouldouyre, Marie-Anne
    Orcel, Philippe
    Richette, Pascal
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) : 230 - 235
  • [45] Brief Report on the Efficacy of Nivolumab in Patients With Previously Treated Advanced Large- Cell Neuroendocrine Cancer of the Lung
    Agar, Camille
    Geier, Margaux
    Leveiller, Guillaume
    Lamy, Regine
    Bizec, Jean-Louis
    Tiercin, Marie
    Bernier, Cyril
    Robinet, Gilles
    Lena, Herve
    Ricordel, Charles
    Corre, Romain
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (04):
  • [46] A Case of Small Cell Lung Cancer Complicated During Nivolumab Administration as Second Line Treatment for Squamous Cell Lung Cancer
    Kimura, T.
    Kondoh, Y.
    Kataoka, K.
    Matsuda, T.
    Yokoyama, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2148 - S2148
  • [47] Myasthenia gravis due to anti-PD-1 treatment for an advanced colon cancer patient: a case report and literature review
    Yu, Hansong
    Wang, Xiaoxiao
    Pan, Yuetong
    Li, Hongyan
    JOURNAL OF NEUROLOGY, 2024, 271 (08) : 5326 - 5332
  • [48] Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literature
    Izumi, Hiroki
    Kodani, Masahiro
    Kurai, Jun
    Takeda, Kenichi
    Okazaki, Ryota
    Yamane, Kohei
    Teruya, Yasuhiko
    Yamamoto, Akihiro
    Sueda, Yuriko
    Yanai, Masaaki
    Tanaka, Natsumi
    Sakamoto, Tomohiro
    Yamaguchi, Kosuke
    Makino, Haruhiko
    Igishi, Tadashi
    Yamasaki, Akira
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (05) : 439 - 446
  • [49] Nivolumab therapy for lung cancer with tracheo-parenchymal fistula A case report
    Yamasaki, Masahiro
    Daido, Wakako
    Funaishi, Kunihiko
    Kawamoto, Kazuma
    Matsumoto, Yu
    Matsumoto, Naoko
    Taniwaki, Masaya
    Ohashi, Nobuyuki
    Hattori, Noboru
    MEDICINE, 2018, 97 (50)
  • [50] Myasthenia gravis and myopathy after nivolumab treatment for non-small cell lung carcinoma: A case report
    Kim, Je-Seong
    Nam, Tai-Seung
    Kim, Jieun
    Kho, Bo-Gun
    Park, Cheol-Kyu
    Oh, In-Jae
    Kim, Young-Chul
    THORACIC CANCER, 2019, 10 (10) : 2045 - 2049